Skip to main content

Intellectual Property

Viewpoints

Filter by:

Podcast Viewpoint Image
In this episode of the EXCLUSIVE RIGHTS: Intellectual Property podcast, IP Members Daniel Weinger and Jonathan Engler discuss how the US International Trade Commission (ITC) evaluates standard essential patents (SEPs) that are litigated in this forum.
Read more
Intellectual Property Viewpoints Thumbnail

An Overview of Shotgun Pleadings in the Federal Courts

August 7, 2023 | Blog | By Joe Rutkowski, Peter Cuomo

Read more
Intellectual Property Viewpoints Thumbnail
Clinical trial related patent applications are often filed prior to the start of the Phase I clinical trial to minimize the risk of invalidation of the resulting patent for public use (35 U.S.C. § 102(a)) based on the clinical trial itself.  This conservative filing strategy is unnecessary for the majority of clinical trial-related inventions, and reduces the value of the patent by prematurely starting the patent term clock.
Read more
Podcast Viewpoint Image

EXCLUSIVE RIGHTS: Intellectual Property — Bad Dog? “Bad Spaniels” at SCOTUS

June 27, 2023 | Podcast | By Daniel Weinger, Karen K. Won

In this episode of the EXCLUSIVE RIGHTS: Intellectual Property podcast, IP Members Daniel Weinger and Karen Won discuss the recent Supreme Court decision in Jack Daniels v. VIP Products addressing whether the “Bad Spaniels” dog chew toy violates the Lanham Act for trademark infringement.
Read more
Podcast Viewpoint Image
In this episode of the EXCLUSIVE RIGHTS: Intellectual Property podcast, Drew DeVoogd and Michael Graif discuss the recent Supreme Court decision in Andy Warhol Foundation for the Visual Arts, Inc. v. Goldsmith, which held that Warhol’s Orange Prince silkscreen portrait did not constitute fair use of a copyrighted photograph of the music legend.
Read more
Intellectual Property Viewpoints Thumbnail

Supreme Court Unanimously Affirms Amgen Repatha® Antibody Patents Invalid for Lack of Enablement

May 25, 2023 | Blog | By Joe Rutkowski, Peter Cuomo, Thomas Wintner, Adam Samansky, Terri Shieh-Newton

Read more
Intellectual Property Viewpoints Thumbnail

Intellectual Property for the Metaverse

May 24, 2023 | Blog | By Frank Gerratana, Amritaa Ganguly

As metaverse-related technology and branding initiatives continue to grow, innovators in the space may need to pursue IP protection. Mintz Member Frank Gerratana and Associate Amritaa Ganguly discuss the use of patents, trademarks, and copyrights to protect innovations and creative activity associated with this new virtual world.
Read more
Podcast Viewpoint Image
In this latest episode of EXCLUSIVE RIGHTS, Members Daniel Weinger and Frank Gerratana, along with Associate Greg Penoyer, explore how high-tech start-ups can set themselves up for IP success. The podcast covers the dos and don’ts related to founding documents, provisional patent applications and strategy, trademarks, open source considerations, and more.
Read more
Intellectual Property Viewpoints Thumbnail

Nothing for free – the real costs of ChatGPT

May 11, 2023 | Blog | By Michael Renaud, Marguerite McConihe, Nana Liu

Read more
Intellectual Property Viewpoints Thumbnail
Successful defense of trade secrets in litigation begins with evaluating valuable confidential information and steps taken to safeguard it before any disputes arise. Trade secret asset management allows companies to effectively frame misappropriation or theft claims and advance arguments at every stage of a trade secrets dispute.
Read more
Technology Viewpoints Thumbnail

Benefits and Legal Risks of Embracing Generative AI Applications

April 5, 2023 | Blog | By Jeremy Glaser, Lorena Niebla

Generative artificial intelligence creates content and work efficiencies but also comes with legal pitfalls. Mintz Venture Capital & Emerging Companies Practice Co-chair Jeremy Glaser and Associate Lorena Niebla look at the technology's potential uses as well as risks related to data privacy, intellectual property, and more.
Read more
Viewpoint Thumbnail

Federal Circuit Affirms Delisting of REMS System Patent from FDA Orange Book

March 6, 2023 | Blog | By Peter Cuomo, Adam Samansky, Peter McFadden

Read more
Viewpoint Thumbnail

Avoiding Pitfalls: IP “Dos and Don’ts” for High-Tech Start Ups

February 27, 2023 | Blog | By Daniel Weinger, Frank Gerratana, Greg Penoyer

Read more
Viewpoint Thumbnail

Lensa: Are AI Art Generators Copyright Infringers?

February 15, 2023 | Blog | By Frank Gerratana, Michael Graif, Sebastian Navarro

Read more
Webinar Reference Image

The New European Patent System: Unitary Patents & Unified Patent Court

January 18, 2023 | Webinar | By Pedro Suarez, Michael Van Loy

Read more

Explore Other Viewpoints: